CD44 and cancer: qRT-PCR performed to validate the microarray results showed that expression of a number of cancer-related genes, including HAS3, CD44, TP63, and SMYD2, was decreased by siRNAs targeting DLEU1, while expression of CDH1 was increased by DLEU1 knockdown.